Overexpression of PFKFB3 is associated with poor prognosis of HCC, and its inhibition resulted in suppression of HCC growth in vitro and in vivo76 and reversed the in vitro sorafenib-resistance of HCC cells77. Here, PFKFB3 is linked to hepatocellular carcinoma.